Paper: Depressive Symptoms and Functional Status in African-American Women with T2D (19th International Nursing Research Congress Focusing on Evidence-Based Practice)

Thursday, 10 July 2008: 8:30 AM

Janice Collins-McNeil, PhD, APRN, BC , University of North Carolina Charlotte, Charlotte, NC

Ezra C. Holston, PhD, MSN, RN , Research & Development/Clinical Research, Hythiam, Inc, Los Angeles, CA

Christopher Edwards, PhD , Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC

Learning Objective 1: Recognize relevant data related to prevalence of depression in African American women with type 2 diabetes (T2D).

Learning Objective 2: Discuss the significance of relationships among depressive symptoms and functional status in middle-aged and older African American women with T2D and incorporate in clinical practice.

Background

Approximately 3.2 million African Americans (AA) have type 2 diabetes (T2D) and experience functional disability. However, few studies have examined the association between depressive symptoms and functional status in AA women with T2D.

Purpose

The secondary data analysis examined the relationships between depressive symptoms and functional status in middle-aged AA women with T2D.

Methods

This cross-sectional, descriptive-correlation design study had a convenience sample of 45 AA women (aged 35-73) enrolled in 3 community-based primary care centers in the southeastern US. Measurements were depressive symptoms (Center for Epidemiological Studies Depression Scale (CES-D), sociodemographic/health information (Personal, Health and Sociodemographic Questionnaire), physiometrics (participants' medical records), and functional status (Basic Activities of Daily Living (BADL) and Intermediate Activities of Daily Living (IADL). Data were analyzed with chi-square, Spearman Rho correlations, and multiple regression analysis. Level of significance was p=.05.

Results

For biometrics, participants averaged high body mass indexes (BMI) (33.6±6.7 kg/m2), high Hemoglobin A1c levels (8.5%±2.65), and high low density lipid levels (116.07±33.18 mg/dL). BADL correlated with CES-D item-6 (r=-.32, p=.03) and CES-D item-13 (r=-.33, p=.03). CES-D item-3 correlated with IADL (r=-.43, p=.003) and BMI (r =.42, p=.005). With backwards elimination regressions, BMI, BADL, IADL, age, and education explained the variance in CES-D item-3 (r-square=.44, p=.0001), item-6 (r-square=.33, p=.006), and total score (r-square=.32, p=.007). Total depressive symptom scores were not correlated with functional status.

Conclusions

Findings suggest that specific depressive symptoms may be unexpressed or unrecognized in AA women with T2D and warrant further investigation.

See more of: Updates on Healthcare Disparities
See more of: Research Sessions – Oral Paper & Posters